Epigenetic-Based Immune Intervention for Rheumatic Diseases

References

• American College of Rheumatology. www.rheumatology.org
   Google Scholar
• Park SH , KimSK , ChoeJYet al. Hypermethylation of EBF3 and IRX1 genes in synovial fibroblasts of patients with rheumatoid arthritis . Mol. Cells   35 ( 4 ), 298 – 304 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sandoval J , EstellerM . Cancer epigenomics: beyond genomics . Curr. Opin. Genet. Dev.   22 ( 1 ), 50 – 55 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Gray SG , DeMeyts P . Role of histone and transcription factor acetylation in diabetes pathogenesis . Diabetes Metab. Res. Rev.   21 ( 5 ), 416 – 433 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Gray SG . Epigenetic treatment of neurological disease . Epigenomics   3 ( 4 ), 431 – 450 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Silman AJ , MacgregorAJ , ThomsonWet al. Twin concordance rates for rheumatoid arthritis. results from a nationwide study . Br. J. Rheumatol.   32 ( 10 ), 903 – 907 ( 1993 ).
   PubMedGoogle Scholar
• Jarvinen P , AhoK . Twin studies in rheumatic diseases . Semin. Arthritis Rheum.   24 ( 1 ), 19 – 28 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Macgregor AJ , SniederH , RigbyASet al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins . Arthritis Rheum.   43 ( 1 ), 30 – 37 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Svendsen AJ , KyvikKO , HouenGet al. On the origin of rheumatoid arthritis. the impact of environment and genes – a population based twin study . PLoS ONE   8 ( 2 ), e57304 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Connolly JJ , HakonarsonH . Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing . J. Biomed. Biotechnol.   798924 ( 2012 ).
   PubMedGoogle Scholar
• Feinberg AP , VogelsteinB . Hypomethylation distinguishes genes of some human cancers from their normal counterparts . Nature   301 ( 5895 ), 89 – 92 ( 1983 ).
   PubMed Web of Science ®Google Scholar
• Ellis JA , MunroJE , ChavezRAet al. Genome-scale case-control analysis of CD4+ T-cell DNA methylation in juvenile idiopathic arthritis reveals potential targets involved in disease . Clin. Epigenetics   4 ( 1 ), 20 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Patel DR , RichardsonBC . Dissecting complex epigenetic alterations in human lupus . Arthritis Res. Ther.   15 ( 1 ), 201 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• A look at the origins of cancer epigenetics. Cancer Discov. 3(7), 713 (2013).
   Google Scholar
• Baylin SB , JonesPA . Epigenetic determinants of cancer . In: Epigenetics . AllisCD , JenuweinT , ReinbergD (Eds). Cold Spring Harbor Press , NY, USA , 457 – 476 ( 2006 ).
   Google Scholar
• Richardson B , ScheinbartL , StrahlerJ , GrossL , HanashS , JohnsonM . Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis . Arthritis Rheum.   33 ( 11 ), 1665 – 1673 ( 1990 ).
   PubMed Web of Science ®Google Scholar
• Javierre BM , FernandezAF , RichterJet al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus . Genome Res.   20 ( 2 ), 170 – 179 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Jeffries MA , DozmorovM , TangY , MerrillJT , WrenJD , SawalhaAH . Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus . Epigenetics   6 ( 5 ), 593 – 601 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Absher DM , LiX , WaiteLLet al. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations . PLoS Genet.   9 ( 8 ), e1003678 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Coit P , JeffriesM , AltorokNet al. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients . J. Autoimmun.   43 , 78 – 84 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lin SY , HsiehSC , LinYCet al. A whole genome methylation analysis of systemic lupus erythematosus. hypomethylation of the IL10 and IL1R2 promoters is associated with disease activity . Genes Immun.   13 ( 3 ), 214 – 220 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhu X , LiangJ , LiF , YangY , XiangL , XuJ . Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus . Int. J. Dermatol.   50 ( 6 ), 697 – 704 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lei W , LuoY , YanKet al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis . Scand. J. Rheumatol.   38 ( 5 ), 369 – 374 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Liu Y , AryeeMJ , PadyukovLet al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis . Nat. Biotechnol.   31 ( 2 ), 142 – 147 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Nakano K , WhitakerJW , BoyleDL , WangW , FiresteinGS . DNA methylome signature in rheumatoid arthritis . Ann. Rheum. Dis.   72 ( 1 ), 110 – 117 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Nakano K , BoyleDL , FiresteinGS . Regulation of DNA methylation in rheumatoid arthritis synoviocytes . J. Immunol.   190 ( 3 ), 1297 – 1303 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bottini N , FiresteinGS . Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors . Nat. Rev. Rheumatol.   9 ( 1 ), 24 – 33 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Whitaker JW , ShoemakerR , BoyleDLet al. An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotype . Genome Med.   5 ( 4 ), 40 ( 2013 ).
   PubMedGoogle Scholar
• Koelsch KA , WebbR , JeffriesMet al. Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse . J. Autoimmun.   41 , 168 – 174 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Han TU , ChoSK , KimT , JooYB , BaeSC , KangC . Association of an activity-enhancing variant of IRAK1 and an MECP2-IRAK1 haplotype with increased susceptibility to rheumatoid arthritis . Arthritis Rheum.   65 ( 3 ), 590 – 598 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Miao CG , HuangC , HuangYet al. MeCP2 modulates the canonical Wnt pathway activation by targeting SFRP4 in rheumatoid arthritis fibroblast-like synoviocytes in rats . Cell. Signal.   25 ( 3 ), 598 – 608 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kohli RM , ZhangY . TET enzymes, TDG and the dynamics of DNA demethylation . Nature   502 ( 7472 ), 472 – 479 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Pastor WA , AravindL , RaoA . TETonic shift: biological roles of TET proteins in DNA demethylation and transcription . Nat. Rev. Mol. Cell Biol.   14 ( 6 ), 341 – 356 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zhang Y , ZhaoM , SawalhaAH , RichardsonB , LuQ . Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus . J. Autoimmun.   41 , 92 – 99 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Cornacchia E , GolbusJ , MaybaumJ , StrahlerJ , HanashS , RichardsonB . Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity . J. Immunol.   140 ( 7 ), 2197 – 2200 ( 1988 ).
   PubMed Web of Science ®Google Scholar
• Richardson BC , StrahlerJR , PivirottoTSet al. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus . Arthritis Rheum.   35 ( 6 ), 647 – 662 ( 1992 ).
   PubMedGoogle Scholar
• Yung RL , QuddusJ , ChrispCE , JohnsonKJ , RichardsonBC . Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo . J. Immunol.   154 ( 6 ), 3025 – 3035 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Minguez P , LetunicI , ParcaL , BorkP . PTMcode: a database of known and predicted functional associations between post-translational modifications in proteins . Nucleic Acids Res.   41 ( D1 ), D306 – D311 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Minguez P , ParcaL , DiellaFet al. Deciphering a global network of functionally associated post-translational modifications . Mol. Syst. Biol.   8 , 599 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Gay S , WilsonAG . The emerging role of epigenetics in rheumatic diseases . Rheumatology (Oxford)   53 ( 3 ), 406 – 414 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Horiuchi M , MorinobuA , ChinT , SakaiY , KurosakaM , KumagaiS . Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts . J. Rheumatol.   36 ( 8 ), 1580 – 1589 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Gillespie J , SavicS , WongCet al. Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients . Arthritis Rheum.   64 ( 2 ), 418 – 422 ( 2012 ).
   PubMedGoogle Scholar
• Kawabata T , NishidaK , TakasugiKet al. Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis . Arthritis Res. Ther.   12 ( 4 ), R133 ( 2010 ).
   PubMedGoogle Scholar
• Huber LC , BrockM , HemmatazadHet al. Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients . Arthritis Rheum.   56 ( 4 ), 1087 – 1093 ( 2007 ).
   PubMedGoogle Scholar
• Kirsh O , SeelerJS , PichlerAet al. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase . EMBO J.   21 ( 11 ), 2682 – 2691 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Gregoire S , TremblayAM , XiaoLet al. Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation . J. Biol. Chem.   281 ( 7 ), 4423 – 4433 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Wang WL , LeeYC , YangWM , ChangWC , WangJM . Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription . Nucleic Acids Res.   36 ( 19 ), 6066 – 6079 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Yang Y , TseAK , LiPet al. Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation . Oncogene   30 ( 19 ), 2207 – 2218 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Chabane N , LiX , FahmiH . HDAC4 contributes to IL-1-induced mPGES-1 expression in human synovial fibroblasts through up-regulation of Egr-1 transcriptional activity . J. Cell. Biochem.   106 ( 3 ), 453 – 463 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Maciejewska-Rodrigues H , KarouzakisE , StrietholtSet al. Epigenetics and rheumatoid arthritis. the role of SENP1 in the regulation of MMP-1 expression . J. Autoimmun.   35 ( 1 ), 15 – 22 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Trenkmann M , BrockM , GayREet al. Expression and function of EZH2 in synovial fibroblasts. epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis . Ann. Rheum. Dis.   70 ( 8 ), 1482 – 1488 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Levy D , KuoAJ , ChangYet al. Lysine methylation of the NF-kappaB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-kappaB signaling . Nat. Immunol.   12 ( 1 ), 29 – 36 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yan K , CaoQ , ReillyCM , YoungNL , GarciaBA , MishraN . Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity . J. Biol. Chem.   286 ( 33 ), 28833 – 28843 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hu N , QiuX , LuoYet al. Abnormal histone modification patterns in lupus CD4+ T cells . J. Rheumatol.   35 ( 5 ), 804 – 810 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Lashine YA , SeoudiAM , SalahS , AbdelazizAI . Expression signature of microRNA-181-a reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus . Clin. Exp. Rheumatol.   29 ( 2 ), 351 – 357 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zhang Q , LongH , LiaoJet al. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus . J. Autoimmun.   37 ( 3 ), 180 – 189 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zhao M , SunY , GaoFet al. Epigenetics and SLE. RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells . J. Autoimmun.   35 ( 1 ), 58 – 69 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Zhao M , WuX , ZhangQet al. RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1 . Arthritis Res. Ther.   12 ( 6 ), R227 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Glant TT , BesenyeiT , KadarAet al. Differentially expressed epigenome modifiers, including aurora kinases A and B, in immune cells in rheumatoid arthritis in humans and mouse models . Arthritis Rheum.   65 ( 7 ), 1725 – 1735 ( 2013 ).
   PubMedGoogle Scholar
• Van Bavel CC , DiekerJW , KroezeYet al. Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus . Ann. Rheum. Dis.   70 ( 1 ), 201 – 207 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zouali M . Epigenetics in lupus . Ann. NY Acad. Sci.   1217 , 154 – 165 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Guo S , LiuY , MaYet al. Systemic lupus erythematosus patients contain significantly less igm against mono-methylated lysine than healthy subjects . PLoS ONE   8 ( 7 ), e68520 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sokolove J , BrombergR , DeaneKDet al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis . PLoS ONE   7 ( 5 ), e35296 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Darrah E , RosenA , GilesJT , AndradeF . Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis . Ann. Rheum. Dis.   71 ( 1 ), 92 – 98 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Auger I , CharpinC , BalandraudN , MartinM , RoudierJ . Autoantibodies to PAD4 and BRAF in rheumatoid arthritis . Autoimmun. Rev.   11 ( 11 ), 801 – 803 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Halvorsen EH , PollmannS , GilboeIMet al. Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity . Ann. Rheum. Dis.   67 ( 3 ), 414 – 417 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Pollmann S , StenslandM , HalvorsenEHet al. Anti-PAD4 autoantibodies in rheumatoid arthritis. levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate . Rheumatol. Int.   32 ( 5 ), 1271 – 1276 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhao J , ZhaoY , HeJ , JiaR , LiZ . Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis . J. Rheumatol.   35 ( 6 ), 969 – 974 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Harris ML , DarrahE , LamGKet al. Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis . Arthritis Rheum.   58 ( 7 ), 1958 – 1967 ( 2008 ).
   PubMedGoogle Scholar
• Kolfenbach JR , DeaneKD , DerberLAet al. Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis . Arthritis Rheum.   62 ( 9 ), 2633 – 2639 ( 2010 ).
   PubMedGoogle Scholar
• Darrah E , GilesJT , OlsML , BullHG , AndradeF , RosenA . Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity . Sci. Transl. Med.   5 ( 186 ), 186ra165 ( 2013 ).
   Web of Science ®Google Scholar
• Liu CL , TangsombatvisitS , RosenbergJMet al. Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies . Arthritis Res. Ther.   14 ( 1 ), R 25 ( 2012 ).
   Web of Science ®Google Scholar
• Wang Y , LiM , StadlerSet al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation . J. Cell Biol.   184 ( 2 ), 205 – 213 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Leshner M , WangS , LewisCet al. PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures . Front. Immunol.   3 , 307 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Rohrbach AS , SladeDJ , ThompsonPR , MowenKA . Activation of PAD4 in NET formation . Front. Immunol.   3 , 360 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Pratesi F ,  DioniI ,  TommasiCet al. Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps .  Ann. Rheum. Dis. doi:10.1136/annrheumdis-2012–202765  ( 2013 )  (Epub ahead of print).  
   PubMed Web of Science ®Google Scholar
• Skene PJ , HenikoffS . Histone variants in pluripotency and disease . Development   140 ( 12 ), 2513 – 2524 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kurumizaka H , HorikoshiN , TachiwanaH , KagawaW . Current progress on structural studies of nucleosomes containing histone H3 variants . Curr. Opin. Struct. Biol.   23 ( 1 ), 109 – 115 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hudson M , MahlerM , PopeJet al. Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis . J. Rheumatol.   39 ( 4 ), 787 – 794 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Russo K , HochS , DimaC , VargaJ , TeodorescuM . Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis . J. Rheumatol.   27 ( 1 ), 142 – 148 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Karreth FA , PandolfiPP . ceRNA cross-talk in cancer: when ce-bling rivalries go awry . Cancer Discov.   3 ( 10 ), 1113 – 1121 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yates LA , NorburyCJ , GilbertRJ . The long and short of microRNA . Cell   153 ( 3 ), 516 – 519 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gurtan AM , SharpPA . The role of miRNAs in regulating gene expression networks . J. Mol. Biol.   425 ( 19 ), 3582 – 3600 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ceribelli A , YaoB , Dominguez-GutierrezPR , NahidMA , SatohM , ChanEK . MicroRNAs in systemic rheumatic diseases . Arthritis Res. Ther.   13 ( 4 ), 229 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hu R , O’connellRM . MicroRNA control in the development of systemic autoimmunity . Arthritis Res. Ther.   15 ( 1 ), 202 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Dai R , AhmedSA . MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases . Transl. Res.   157 ( 4 ), 163 – 179 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Goldring MB , MarcuKB . Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritis . Trends Mol. Med.   18 ( 2 ), 109 – 118 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Urdinguio RG , FernandezAF , Lopez-NievaPet al. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome . Epigenetics   5 ( 7 ), 656 – 663 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Miao CG , YangYY , HeXet al. New advances of microRNAs in the pathogenesis of rheumatoid arthritis, with a focus on the crosstalk between DNA methylation and the microRNA machinery . Cell. Signal.   25 ( 5 ), 1118 – 1125 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Filková M ,  AradiB ,  ŠenoltLet al. Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis .  Ann. Rheum. Dis.   doi:10.1136/annrheumdis-2012–202815  ( 2013 )  (Epub ahead of print) .
   Google Scholar
• Zhu S , PanW , SongXet al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha . Nat. Med.   18 ( 7 ), 1077 – 1086 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Pauley KM , StewartCM , GaunaAEet al. Altered miR-146a expression in Sjogren’s syndrome and its functional role in innate immunity . Eur J. Immunol.   41 ( 7 ), 2029 – 2039 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hashemi M , Eskandari-NasabE , ZakeriZet al. Association of pre-miRNA-146a rs2910164 and premiRNA-499 rs3746444 polymorphisms and susceptibility to rheumatoid arthritis . Mol. Med. Rep.   7 ( 1 ), 287 – 291 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wang H , PengW , OuyangX , LiW , DaiY . Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus . Transl. Res.   160 ( 3 ), 198 – 206 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhao S , WangY , LiangYet al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1 . Arthritis Rheum.   63 ( 5 ), 1376 – 1386 ( 2011 ).
   PubMedGoogle Scholar
• Pan W , ZhuS , YuanMet al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1 . J. Immunol.   184 ( 12 ), 6773 – 6781 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Qin H , ZhuX , LiangJet al. MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1 . J. Dermatol. Sci.   69 ( 1 ), 61 – 67 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Carlsen AL , SchetterAJ , NielsenCTet al. Circulating microRNA expression profiles associated with systemic lupus erythematosus . Arthritis Rheum.   65 ( 5 ), 1324 – 1334 ( 2013 ).
   PubMedGoogle Scholar
• Zhang H , ZhaoM , LvZet al. MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer . Cell. Physiol. Biochem.   31 ( 1 ), 56 – 65 ( 2013 ).
   PubMedGoogle Scholar
• Qiu S , HuangD , YinDet al. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme . Biochim. Biophys. Acta   1832 ( 10 ), 1697 – 1707 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Guan YJ , YangX , WeiL , ChenQ . MiR-365: a mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4 . FASEB J.   25 ( 12 ), 4457 – 4466 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Tuddenham L , WheelerG , Ntounia-FousaraSet al. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells . FEBS Lett.   580 ( 17 ), 4214 – 4217 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Li Z , HassanMQ , JafferjiMet al. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation . J. Biol. Chem.   284 ( 23 ), 15676 – 15684 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Eades G , YaoY , YangM , ZhangY , ChumsriS , ZhouQ . miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells . J. Biol. Chem.   286 ( 29 ), 25992 – 26002 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Shakibaei M , ShayanP , BuschFet al. Resveratrol mediated modulation of Sirt-1/Runx2 promotes osteogenic differentiation of mesenchymal stem cells. potential role of Runx2 deacetylation . PLoS ONE   7 ( 4 ), e35712 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wang G , TamLS , LiEKet al. Serum and urinary free microRNA level in patients with systemic lupus erythematosus . Lupus   20 ( 5 ), 493 – 500 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hu N , LongH , ZhaoM , YinH , LuQ . Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice . Scand. J. Rheumatol.   38 ( 6 ), 464 – 471 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Gebert LF , RebhanMA , CrivelliSE , DenzlerR , StoffelM , HallJ . Miravirsen (SPC3649) can inhibit the biogenesis of miR-122 . Nucleic Acids Res.   42 ( 1 ), 609 – 621 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Janssen HL , ReesinkHW , LawitzEJet al. Treatment of HCV infection by targeting microRNA . N. Engl. J. Med.   368 ( 18 ), 1685 – 1694 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Reilly CM , MishraN , MillerJMet al. Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid . J. Immunol.   173 ( 6 ), 4171 – 4178 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Mishra N , ReillyCM , BrownDR , RuizP , GilkesonGS . Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse . J. Clin. Invest.   111 ( 4 ), 539 – 552 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Garcia BA , BusbySA , ShabanowitzJ , HuntDF , MishraN . Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition . J. Proteome Res.   4 ( 6 ), 2032 – 2042 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Grabiec AM , TakPP , ReedquistKA . Function of histone deacetylase inhibitors in inflammation . Crit. Rev. Immunol.   31 ( 3 ), 233 – 263 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Grabiec AM , ReedquistKA . The ascent of acetylation in the epigenetics of rheumatoid arthritis . Nat. Rev. Rheumatol.   9 ( 5 ), 311 – 318 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Saouaf SJ , LiB , ZhangGet al. Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis . Exp. Mol. Pathol.   87 ( 2 ), 99 – 104 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Kristensen LH , NielsenAL , HelgstrandCet al. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor . FEBS J.   279 ( 11 ), 1905 – 1914 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Nakagawa-Yagi Y , SatoY , MatsumotoEet al. Pharmacological modulation of histone demethylase activity by a small molecule isolated from subcritical water extracts of Sasa senanensis leaves prolongs the lifespan of Drosophila melanogaster . BMC Complement. Altern. Med.   12 , 101 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kruidenier L , ChungCW , ChengZet al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response . Nature   488 ( 7411 ), 404 – 408 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Jones JE , SlackJL , FangPet al. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors . ACS Chem. Biol.   7 ( 1 ), 160 – 165 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Slack JL , CauseyCP , ThompsonPR . Protein arginine deiminase 4: a target for an epigenetic cancer therapy . Cell. Mol. Life Sci.   68 ( 4 ), 709 – 720 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wang Y , LiP , WangSet al. Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity . J. Biol. Chem.   287 ( 31 ), 25941 – 25953 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Dreyton CJ, Jones JE, Knuckley BA et al. Optimization and characterization of a pan protein arginine deiminase (PAD) inhibitor. In: Probe Reports from the NIH Molecular Libraries Program. National Center for Biotechnology Information (US) (Ed.). Bethesda, MD, USA (2010).
   Google Scholar
• Knuckley B , CauseyCP , JonesJEet al. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3 . Biochemistry   49 ( 23 ), 4852 – 4863 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Bozdag M , DrekerT , HenryCet al. Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors . Bioorg. Med. Chem. Lett.   23 ( 3 ), 715 – 719 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lin NY , BeyerC , GiesslAet al. Autophagy regulates TNFalpha-mediated joint destruction in experimental arthritis . Ann. Rheum. Dis.   72 ( 5 ), 761 – 768 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Knight JS , ZhaoW , LuoWet al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus . J. Clin. Invest.   123 ( 7 ), 2981 – 2993 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Baer C , ClausR , PlassC . Genome-wide epigenetic regulation of miRNAs in cancer . Cancer Res.   73 ( 2 ), 473 – 477 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lopez-Serra P , EstellerM . DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer . Oncogene   31 ( 13 ), 1609 – 1622 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Jiang M , XiangY , WangDet al. Dysregulated expression of miR-146a contributes to age-related dysfunction of macrophages . Aging Cell   11 ( 1 ), 29 – 40 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Hu R , WallaceJ , DahlemTJ , GrunwaldDJ , O’connellRM . Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs) . PLoS ONE   8 ( 5 ), e63074 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Baird AM , GraySG , O’ByrneKJ . Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer . PLoS ONE   6 ( 1 ), e14593 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Baird AM , GraySG , O’ByrneKJ . IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF . Eur. J. Cancer   47 ( 12 ), 1908 – 1918 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hofmann SR , Rosen-WolffA , TsokosGC , HedrichCM . Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury . Clin. Immunol.   143 ( 2 ), 116 – 127 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Rauen T , HedrichCM , JuangYT , TenbrockK , TsokosGC . cAMP-responsive element modulator (CREM)alpha protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus . J. Biol. Chem.   286 ( 50 ), 43437 – 43446 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Croxford AL , MairF , BecherB . IL-23: one cytokine in control of autoimmunity . Eur J. Immunol.   42 ( 9 ), 2263 – 2273 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Guo YY , WangNZ , ZhaoS , HouLX , XuYB , ZhangN . Increased interleukin-23 is associated with increased disease activity in patients with rheumatoid arthritis . Chin. Med. J. (Engl.)   126 ( 5 ), 850 – 854 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kim HR , ChoML , KimKWet al. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways . Rheumatology (Oxford)   46 ( 1 ), 57 – 64 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Kim J , KangS , KwonG , KooS . Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis . Ann. Lab. Med.   33 ( 1 ), 52 – 59 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kyttaris VC , KampagianniO , TsokosGC . Treatment with anti-interleukin 23 antibody ameliorates disease in lupus-prone mice . Biomed. Res. Int.   861028 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Baird AM , LeonardJ , NaickerKM , KilmartinL , O’byrneKJ , GraySG . IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer . Lung Cancer   79 ( 1 ), 83 – 90 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Cathcart MC , GraySG , BairdAMet al. Prostacyclin synthase expression and epigenetic regulation in nonsmall cell lung cancer . Cancer   117 ( 22 ), 5121 – 5132 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Grabiec AM , KorchynskyiO , TakPP , ReedquistKA . Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay . Ann. Rheum. Dis.   71 ( 3 ), 424 – 431 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Quddus J , JohnsonKJ , GavalchinJet al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice . J. Clin. Invest.   92 ( 1 ), 38 – 53 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Vojinovic J , DamjanovN , D’urzoCet al. Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis . Arthritis Rheum.   63 ( 5 ), 1452 – 1458 ( 2011 ).
   PubMedGoogle Scholar
• Laitinen K , GyllingH . Dose-dependent LDL-cholesterol lowering effect by plant stanol ester consumption: clinical evidence . Lipids Health Dis.   11 , 140 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Link A , BalaguerF , GoelA . Cancer chemoprevention by dietary polyphenols: promising role for epigenetics . Biochem Pharmacol   80 ( 12 ), 1771 – 1792 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Cuevas A , SaavedraN , SalazarLA , AbdallaDS . Modulation of immune function by polyphenols: possible contribution of epigenetic factors . Nutrients   5 ( 7 ), 2314 – 2332 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lawless MW , O’byrneKJ , GraySG . Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy . J. Cell. Mol. Med.   13 ( 9A ), 2800 – 2821 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Chandran B , GoelA . A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis . Phytother. Res.   26 ( 11 ), 1719 – 1725 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lee H , KimH , LeeG , ChungHS , BaeH . Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand black/white mice . Br. J. Nutr.   110 ( 1 ), 69 – 76 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bao B , AliS , BanerjeeSet al. Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression . Cancer Res.   72 ( 1 ), 335 – 345 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Foxley S , ZamoraM , HackBet al. Curcumin aggravates CNS pathology in experimental systemic lupus erythematosus . Brain Res.   1504 , 85 – 96 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Thomasset S , TellerN , CaiHet al. Do anthocyanins and anthocyanidins, cancer chemopreventive pigments in the diet, merit development as potential drugs ? Cancer Chemother. Pharmacol.   64 ( 1 ), 201 – 211 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Seong AR , YooJY , ChoiKet al. Delphinidin, a specific inhibitor of histone acetyltransferase, suppresses inflammatory signaling via prevention of NF-kappaB acetylation in fibroblast-like synoviocyte MH7A cells . Biochem. Biophys. Res. Commun.   410 ( 3 ), 581 – 586 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hafeez BB , SiddiquiIA , AsimMet al. A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo. involvement of nuclear factor-kappaB signaling . Cancer Res.   68 ( 20 ), 8564 – 8572 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Beher D , WuJ , CumineSet al. Resveratrol is not a direct activator of SIRT1 enzyme activity . Chem. Biol. Drug Des.   74 ( 6 ), 619 – 624 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hubbard BP , GomesAP , DaiHet al. Evidence for a common mechanism of SIRT1 regulation by allosteric activators . Science   339 ( 6124 ), 1216 – 1219 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Park SJ , AhmadF , PhilpAet al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases . Cell   148 ( 3 ), 421 – 433 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Venturelli S , BergerA , BockerAet al. Resveratrol as a Pan-HDAC inhibitor alters the acetylation status of histone proteins in human-derived hepatoblastoma cells . PLoS ONE   8 ( 8 ), e73097 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Byun HS , SongJK , KimYRet al. Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes . Rheumatology (Oxford)   47 ( 3 ), 301 – 308 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Elmali N , BaysalO , HarmaA , EsenkayaI , MizrakB . Effects of resveratrol in inflammatory arthritis . Inflammation   30 ( 1–2 ), 1 – 6 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Glehr M , Fritsch-BreisachM , LohbergerBet al. Influence of resveratrol on rheumatoid fibroblast-like synoviocytes analysed with gene chip transcription . Phytomedicine   20 ( 3–4 ), 310 – 318 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Nakayama H , YaguchiT , YoshiyaS , NishizakiT . Resveratrol induces apoptosis MH7A human rheumatoid arthritis synovial cells in a sirtuin 1-dependent manner . Rheumatol. Int.   32 ( 1 ), 151 – 157 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Tian J , ChenJW , GaoJS , LiL , XieX . Resveratrol inhibits TNF-alpha-induced IL-1beta, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway . Rheumatol. Int.   33 ( 7 ), 1829 – 1835 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gerhauser C . Epigenetic impact of dietary isothiocyanates in cancer chemoprevention . Curr. Opin. Clin. Nutr. Metab. Care   16 ( 4 ), 405 – 410 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Clarke JD , RiedlK , BellaD , SchwartzSJ , StevensJF , HoE . Comparison of isothiocyanate metabolite levels and histone deacetylase activity in human subjects consuming broccoli sprouts or broccoli supplement . J. Agric. Food Chem.   59 ( 20 ), 10955 – 10963 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Park JH , KimJW , LeeCMet al. Sulforaphane inhibits the Th2 immune response in ovalbumin-induced asthma . BMB Rep.   45 ( 5 ), 311 – 316 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kong JS , YooSA , KimHSet al. Inhibition of synovial hyperplasia, rheumatoid T cell activation, and experimental arthritis in mice by sulforaphane, a naturally occurring isothiocyanate . Arthritis Rheum.   62 ( 1 ), 159 – 170 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• James D , DevarajS , BellurP , LakkannaS , ViciniJ , BoddupalliS . Novel concepts of broccoli sulforaphanes and disease: induction of phase II antioxidant and detoxification enzymes by enhanced-glucoraphanin broccoli . Nutr. Rev.   70 ( 11 ), 654 – 665 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Christiansen B , BellostasMuguerza N , PetersenAMet al. Ingestion of broccoli sprouts does not improve endothelial function in humans with hypertension . PLoS ONE   5 ( 8 ), e12461 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Armah CN , TrakaMH , DaintyJRet al. A diet rich in high-glucoraphanin broccoli interacts with genotype to reduce discordance in plasma metabolite profiles by modulating mitochondrial function . Am. J. Clin. Nutr.   98 ( 3 ), 712 – 722 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yang ML , GeeAJ , GeeRJet al. Lupus autoimmunity altered by cellular methylation metabolism . Autoimmunity   46 ( 1 ), 21 – 31 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Strickland FM , HewagamaA , WuAet al. Diet influences expression of autoimmune-associated genes and disease severity by epigenetic mechanisms in a transgenic mouse model of lupus . Arthritis Rheum.   65 ( 7 ), 1872 – 1881 ( 2013 ).
   PubMedGoogle Scholar
• Ha MK , SongYH , JeongSJet al. Emodin inhibits proinflammatory responses and inactivates histone deacetylase 1 in hypoxic rheumatoid synoviocytes . Biol. Pharm. Bull.   34 ( 9 ), 1432 – 1437 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yap TA , GerlingerM , FutrealPA , PusztaiL , SwantonC . Intratumor heterogeneity: seeing the wood for the trees . Sci. Transl. Med.   4 ( 127 ), 127ps110 ( 2012 ).
   Web of Science ®Google Scholar
• Swanton C . Intratumor heterogeneity: evolution through space and time . Cancer Res.   72 ( 19 ), 4875 – 4882 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• You S , ChoCS , LeeI , HoodL , HwangD , KimWU . A systems approach to rheumatoid arthritis . PLoS ONE   7 ( 12 ), e51508 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• The Structural Genomics Consortium .  www.thesgc.org/epigenetics
   Google Scholar
• Davidson RK , JuppO , DeFerrars Ret al. Sulforaphane represses matrix-degrading proteases and protects cartilage from destruction in vitro and in vivo . Arthritis Rheum . 65 ( 12 ), 3130 ( 2013 ).
   PubMedGoogle Scholar